Publications by authors named "Malin Berling"

Claim this Profile
C
Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Malin Berling, Mohammad A Chaudhary, Yong Yuan, Nebibe Varol, Peter Dale

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada.
Zalmai Hakimi, Jameel Nazir, Charles McCrea, Malin Berling, Francis Fatoye

J Med Econ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK.
Jameel Nazir, Malin Berling, Charles McCrea, Francis Fatoye, Sally Bowditch

Pharmacoecon Open· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis